Adverse effect of anticoagulants, initial encounter

This code signifies a patient experiencing an unintended and harmful reaction to an anticoagulant medication during the period when the adverse effect is actively being treated. This could manifest as bleeding complications, thrombotic events, or other systemic responses directly attributable to the anticoagulant. The "initial encounter" designation indicates that the patient is receiving active treatment for the adverse effect.

Apply this code when a patient presents to a healthcare facility for the first time for treatment of an adverse reaction to an anticoagulant, such as warfarin, heparin, or a direct oral anticoagulant (DOAC). This includes scenarios like emergency department visits for uncontrolled bleeding, hospital admissions for anticoagulant-induced thrombocytopenia, or outpatient visits for initial management of a new skin rash caused by the medication.

• Always sequence this code first if it is the primary reason for the encounter.
• Code the specific manifestation of the adverse effect (e.g., hemorrhage, rash) as an additional diagnosis.
• Ensure documentation clearly links the adverse effect to the anticoagulant and specifies that it's the initial treatment encounter.